Healthcare | July 05, 2022
Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries
Medicines, including insulin, to be available in 40 lower-income countries
Medicines, including insulin, to be available in 40 lower-income countries
Govt committed to supporting pharma companies with industry-friendly policies
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Strengthens investment in channels of the future to expand patient reach
The Congress was held on June, 20-21, 2022 in Berlin, Germany
Subscribe To Our Newsletter & Stay Updated
